All
First Patients Dosed With Novel Inhibitor in Trial on Relapsed or Refractory AML Subset
February 11th 2023Researchers conducting a phase 2 trial recently dosed the first patients with a novel menin inhibitor for the treatment of patients with NPM1-mutant relapsed or refractory acute myeloid leukemia.
Cancer Survivor to Attend the Super Bowl, Bodybuilder Dies of Cancer and More
February 10th 2023From a cancer survivor who will attend the Super Bowl thanks to the Make-a-Wish foundation to the death of a former professional bodybuilder from the disease, here’s what is happening in the oncology space this week.